Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Bjorkman: Improving Potency and Breadth of Natural bNAbs |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2012-08-30 |
| Study Made Public: | 2015-10-19 |
Title
Improved anti-HIV-1 reagents
Description
CAVD 385 is an immunogencity study to evaluate various engineered forms of broadly neutralizing antibodies (bNAbs) across large viral panels.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.